Pregnancy Clinical Trial
— IAFACTOfficial title:
Technical Factors of Embryo Transfer Procedure That Might Affect the Outcome
Verified date | May 2020 |
Source | Iakentro Fertility Centre |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Analysis our Embryo transfer data, prospectively collected during the last 6 years (2014- 2019), performed by the same operator YP, who has been doing embryo transfers since 1984. All factors that might impact the embryo transfer will be analyzed. We want to see which factors that influence the success rate are not related to the subjectivity of the operator and could be adjusted through different approaches.
Status | Completed |
Enrollment | 3512 |
Est. completion date | December 30, 2019 |
Est. primary completion date | December 30, 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 49 Years |
Eligibility |
Inclusion Criteria: - Women undergoing embryo transfer after IVF Exclusion Criteria: - Women with known embryo implantation issues |
Country | Name | City | State |
---|---|---|---|
Greece | IAKENTRO Fertility Center | Thessaloniki |
Lead Sponsor | Collaborator |
---|---|
Iakentro Fertility Centre |
Greece,
Prapas N, Prapas Y, Panagiotidis Y, Prapa S, Vanderzwalmen P, Makedos G. Cervical dilatation has a positive impact on the outcome of IVF in randomly assigned cases having two previous difficult embryo transfers. Hum Reprod. 2004 Aug;19(8):1791-5. Epub 200 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of patients with bhCG positive test after embryo transfer | Number of patients bhCG positive up to12 days after embryo transfer | Number of patients bhCG positive up to12 days after embryo transfer | |
Primary | Number of patients with on going clinical pregnancy | Number of patients with on going clinical pregnancy up to12 weeks after embryo transfer | Number of patients with on going clinical pregnancy up to 12 weeks after embryo transfer | |
Primary | Number of live births after embryo transfer | Number oflive birth up to9 months after embryo transfer | Number oflive birth up to 9 months after embryo transfer | |
Secondary | Percentage of fullnes of bladder | Percentage of fullness of the bladder during embryo transfer | At the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer | |
Secondary | Endometrial thickness | Endometrial thickness prior to embryo transfer | prior to embryo transfer | |
Secondary | Uterine axe orientation | Uterine axe orientation during embryo transfer | At the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer | |
Secondary | Type of embryo transfer catheter | Type of embryo transfer catheter used in the procedure | At the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer | |
Secondary | Distance from the fundus of the embryo release | Distance from the fundus of the embryo release | At the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer | |
Secondary | Embryo retained in the catheter | Embryo retained in the catheter | Number of patients who underwent embryo transfer and the embryo was retained in the catheter at the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02528136 -
The Clinical Carbetocin Myocardium Trial
|
Phase 4 |